BLFS - Latest News
BioLife Solutions, Inc. (BLFS), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.
Market capitalization stands near $1.71B. Trailing twelve-month P/E ratio is 33.97. Beta to the broader market is 1.90.
The article list below shows the most recent BLFS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent BLFS Headlines
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
zacks.com - Aug 6, 2026
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.
BioLife Solutions Reports Second Quarter 2026 Financial Results
prnewswire.com - Aug 6, 2026
Total revenue of $28. 5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted gross margin of 65% GAAP net income of $45.
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
businesswire.com - Jul 24, 2026
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
zacks.com - Jul 23, 2026
RGEN's $1. 5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopreservation products and expected revenue and EPS be
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
marketbeat.com - Jul 22, 2026
Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a transaction valued at approximately $1. 5 billion, a
How News Affects BLFS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BLFS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked BLFS news questions
- What is the latest BLFS news headline?
- The most recent BLFS headline (Aug 6, 2026) is "BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the BLFS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What BLFS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual BLFS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.